Preview

Medical Genetics

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Molecular genetic analysis of Rubinstein–Taybi syndrome in Russia

https://doi.org/10.25557/2073-7998.2025.11.78-81

Abstract

Rubinstein-Taybi Syndrome (RTS) is a rare pathology, characterized by intellectual disability, developmental delays and a specific set of phenotypic features, with various anomalies in internal organs. The diagnostic algorithm includes detecting mutations in two main genes: CREBBP and EP300. This study presents the results of molecular-genetic analysis of 158 Russian patients with RTS: pathogenic and likely pathogenic variants were identified in 70 patients (42.4%), of which 62 (39%) were associated with the CREBBP gene and 4 cases (2%) with the EP300 gene. One patient was found to have a pathogenic variant in the SRCAP gene, which is associated with the development of a phenotypically similar condition known as Floating-Harbor Syndrome (FHS). There are opportunities for improvement in diagnostic principles.

About the Authors

O. R. Ismagilova
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



T. S. Beskorovainaya
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



M. S. Petukhova
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



I. V. Anisimova
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



L. A. Bessonova
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



T. V. Markova
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



E. A. Shestopalova
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



S. A. Repina
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



O. A. Levchenko
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



D. M. Guseva
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



N. A. Demina
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



R. M. Zinchenko
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



I. A. Mishina
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



N. A. Semenova
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



V. A. Galkina
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



A. O. Borovikov
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



P. A. Sparber
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



O. A. Zemlianaia
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



A. I. Kalinkin
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



A. S. Tanas
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



A. V. Efremova
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



D. V. Zaletaev
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



V. V. Strelnikov
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



V. V. Strelnikov
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



A. V. Polyakov
Research Centre for Medical Genetics
Russian Federation

1, Moskvorechie st., Moscow, 115478



References

1. Rubinstein J. H. Broad thumb-hallux (Rubinstein-Taybi) syndrome 1957–1988. Am. J. Med. Genet. 1990;37(S6):3-16. doi: 10.1002/ ajmg.1320370603

2. Roelfsema J. H., White S.J., Ariyürek Y., et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am. J. Hum. Genet. 2005;76(4):572-580. doi: 10.1086/429130

3. Spena S., Gervasini C., Milani D. Ultra-rare syndromes: the example of Rubinstein–Taybi syndrome. J. Pediatr. Genet. 2015;4(03):177-186. doi: 10.1055/s-0035-1564571

4. Zemlianaia O.A., Kalinkin A.I., Tanas A.S., et al. Kosvennaya diagnostika sindroma Rubinshteyna-Teybi 1 tipa s primeneniyem metodov targetnogo analiza urovnya metilirovaniya DNK [Indirect diagnostics of type 1 Rubinstein-Taybi syndrome using methods of targeted analysis of DNA methylation level]. Meditsinskaya genetika [Medical Genetics]. 2024;23(8):13-22. (In Russ.) https://doi.org/10.25557/2073-7998.2024.08.13-22

5. Cross E., Duncan-Flavell, P. J., Howarth, R. J. et al. Screening of a large Rubinstein–Taybi cohort identified many novel variants and emphasizes the importance of the CREBBP histone acetyltransferase domain. Am. J. Med. Genet. Part A. 2020;182(11):2508-2520. doi: 10.1002/ajmg.a.61813

6. Coupry I., Roudaut, C., Stef, M. et al. Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome. J. Med. Genet. 2002;39(6):415-421. doi: 10.1136/jmg.39.6.415

7. Bartsch O., Schmidt, S., Richter, M. et al. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein– Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum. Genet. 2005;117:485-493. doi: 10.1007/s00439-005-1331-y

8. Bentivegna A., Milani, D., Gervasini, C. et al. Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients. BMC Med. Genet. 2006;7;1-13. doi: 10.1186/1471-2350-7-77

9. Schorry E. K., Keddache, M., Lanphear, N. et al. Genotype– phenotype correlations in Rubinstein–Taybi syndrome. Am. J. Med. Genet. Part A. 2008;146(19):2512-2519. doi: 10.1002/ajmg.a.32424

10. Wincent J., Luthman, A., van Belzen, M. et al. CREBBP and EP300 mutational spectrum and clinical presentations in a cohort of Swedish patients with Rubinstein–Taybi syndrome. Mol. Genet. Genomic Med. 2016;4(1):39-45. doi: 10.1002/mgg3.177

11. Woods S. A., Robinson, H. B., Kohler, L. J. et al. Exome sequencing identifies a novel EP300 frame shift mutation in a patient with features that overlap Cornelia de Lange syndrome. Am. J. Med. Genet. Part A. 2014;164(1):251-258. doi: 10.1002/ajmg.a.36237

12. Cucco F., Sarogni, P., Rossato, S. et al. Pathogenic variants in EP300 and ANKRD11 in patients with phenotypes overlapping Cornelia de Lange syndrome. Am. J. Med. Genet. Part A. 2020;182(7):1690-1696. doi: 10.1002/ajmg.a.61611

13. Negri G., Magini, P., Milani, D. et al. Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein–Taybi syndrome: the interconnections of epigenetic machinery disorders. Hum. Genet. 2019;138:257-269. doi: 10.1007/s00439-019-01985-y

14. Di Fede E., Massa, V., Augello, B. et al. Expanding the phenotype associated to KMT2A variants: overlapping clinical signs between Wiedemann–Steiner and Rubinstein–Taybi syndromes. Eur. J. Hum. Genet. 2021;29(1):88-98. doi: 10.1038/s41431-020-0679-8

15. Bjornsson H. T. The Mendelian disorders of the epigenetic machinery. Genome Res. 2015;25(10):1473-1481 doi: 10.1101/ gr.190629.115

16. Van Gils J., Magdinier, F., Fergelot, P., Lacombe, D. RubinsteinTaybi syndrome: a model of epigenetic disorder. Genes. 2021;12(7)968. doi: 10.3390/genes12070968


Review

For citations:


Ismagilova O.R., Beskorovainaya T.S., Petukhova M.S., Anisimova I.V., Bessonova L.A., Markova T.V., Shestopalova E.A., Repina S.A., Levchenko O.A., Guseva D.M., Demina N.A., Zinchenko R.M., Mishina I.A., Semenova N.A., Galkina V.A., Borovikov A.O., Sparber P.A., Zemlianaia O.A., Kalinkin A.I., Tanas A.S., Efremova A.V., Zaletaev D.V., Strelnikov V.V., Strelnikov V.V., Polyakov A.V. Molecular genetic analysis of Rubinstein–Taybi syndrome in Russia. Medical Genetics. 2025;24(11):78-81. (In Russ.) https://doi.org/10.25557/2073-7998.2025.11.78-81

Views: 12


ISSN 2073-7998 (Print)